Deep learning-based prediction of H3K27M alteration in diffuse midline gliomas based on whole-brain MRI

Bowen Huang1, Yuekang Zhang1, Qing Mao1

  • 1Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, China.

Cancer Medicine
|July 18, 2023
PubMed
Abstract

Insights

A deep learning model accurately predicts H3K27M mutation status in diffuse midline gliomas (DMGs) using whole-brain MRI. This automated approach aids in prognosis for DMG patients, overcoming pathological acquisition challenges.

Area of Science:

  • Neuro-oncology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Diffuse midline gliomas (DMGs) prognosis is linked to H3K27M mutation status.
  • Pathological acquisition poses challenges for accurate H3K27M status determination in DMGs.

Purpose of the Study:

  • To develop a fully automated deep learning model for predicting H3K27M alteration status in DMGs.
  • To leverage whole-brain MRI for non-invasive H3K27M status prediction.

Main Methods:

  • Utilized deep learning on whole-brain MRI data from 235 DMG patients (WCHSU and CSNH).
  • Employed model pretraining on normal human head MRI and cotraining for classification and tumor segmentation tasks.
  • Integrated information interaction between classification and segmentation to enhance predictive accuracy.

Main Results:

  • Achieved average classification accuracies of 90.5% (training) and 85.1% (external test).
  • Demonstrated strong performance with average AUROCs of 94.18% (training) and 87.64% (external test).
  • Reported average AUPRCs of 93.26% (training) and 85.4% (external test), with pretraining and cotraining improving accuracy.

Conclusions:

  • The developed deep learning model shows excellent performance in predicting H3K27M alteration status in DMGs.
  • The model's reproducibility and generalization capabilities were validated on an external dataset.
  • This automated approach offers a promising tool for DMG patient management and prognosis.

Related Concept Videos